[1] |
Gao Y,Zhao Y,Yao J,et al.Wogonin suppresses human alveolar adenocarcinoma cell A549 invasion and metastasis induced by IL-6[J].J China Pharm Univ(中国药科大学学报),2015,46(3):345-349.
|
[2] |
Santos AA,Matos AJ.Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours.Part 2:invasion,angiogenesis,metastasis and therapy[J].Vet J,2015,205(2):144-153.
|
[3] |
Romero-Tabarez M,Jansen R,Sylla M,et al.7-O-malonyl macrolactin A,a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus,Vancomycin-resistant enterococci,and a small-colony variant of Burkholderia cepacia[J].Antimicrob Agents Chemother,2006,50(5):1701-1709.
|
[4] |
Kim DH,Kim HK,Kim KM,et al.Antibacterial activities of macrolactin A and 7-O-succinyl macrolactin A from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus[J].Arch Pharm Res,2011,34(1):147-152.
|
[5] |
Wu X,Zhu Y,Yan H,et al.Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells[J].BMC Cancer,2010,9(10):269.
|
[6] |
Reck M,Popat S,Reinmuth N,et al.Metastatic non-small-cell lung cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2014,25(Suppl 3):iii27-39.
|
[7] |
Spano D,Heck C,De Antonellis P,et al.Molecular networks that regulate cancer metastasis[J].Semin Cancer Biol,2012,22(3):234-249.
|
[8] |
Han B,Guo Z,Ma Y,et al.Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy[J].Int J Clin Exp Pathol,2015,8(4):4113-4119.
|
[9] |
Al-Taweel AM,Perveen S,Fawzy GA,et al.Cytotoxicity assessment of six different extracts of abelia triflora leaves on A549 human lung adenocarcinoma cells[J].Asian Pac J Cancer Prev,2015,16(11):4641-4645.
|
[10] |
Regmi SC,Park SY,Kim SJ,et al.The anti-tumor activity of succinyl macrolactin A is mediated through the β-catenin destruction complex via the suppression of tankyrase and PI3K/Akt[J].PLoS One,2015,10(11):e0141753.
|
[11] |
Kang Y,Regmi SC,Kim MY,et al.Anti-angiogenic activity of macrolactin A and its succinyl derivative is mediated through inhibition of class I PI3K activity and its signaling[J].Arch Pharm Res,2015,38(2):249-260.
|
[12] |
Zhao R,Chen M,Jiang Z,et al.Platycodin-D induced autophagy in non-small cell lung cancer cells via PI3K/Akt/mTOR and MAPK signaling pathways[J].J Cancer,2015,6(7):623-631.
|
[13] |
Gu CP,Que FC,Li YL,et al.Cisplatin inhibits survival of human esophageal squamous carcinoma cells via p53 activation[J].J China Pharm Univ(中国药科大学学报),2016,47(1):90-94.
|
[14] |
Liu W, Ren H, Ren J, et al. The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma[J].Mediators Inflamm,2013:651207.
|
[15] |
Ku JH,Seo SY,Kwak C,et al.The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells[J].Urol Oncol,2012,30(5):562-568.
|
[16] |
Shay G,Lynch CC,Fingleton B.Moving targets:emerging roles for MMPs in cancer progression and metastasis[J].Matrix Biol,2015,44-46:200-206.
|
[17] |
Wang R,Ke ZF,Wang F,et al.GOLPH3 overexpression is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through upregulating MMP-2 and MMP-9[J].Cell Physiol Biochem,2015,35(3):969-982.
|
[18] |
Zhang H,Guo M,Chen JH,et al.Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway[J].Cell Physiol Biochem,2014,33(4):991-1002.
|
[19] |
Park S,Regmi SC,Park SY,et al.Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase/Akt/mTOR and NF-κB signaling pathways[J].Eur J Pharmacol,2014,735:184-192.
|
[20] |
Ponnusamy MP,Seshacharyulu P,Lakshmanan I,et al.Emerging role of mucins in epithelial to mesenchymal transition[J].Curr Cancer Drug Targets,2013,13(9):945-956.
|